Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT04443530 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial
NCT04443530 · ClinicalTrials.gov record · last posted 2026-06-26

Evaluation of Effectiveness and Safety of Ultimaster™ Tansei™ Stent and/or Ultimaster Nagomi™ Stent in Routine Clinical Practice

Study acronym: IRIS Tansei
StatusRecruiting
PhaseNot specified
Started2020-09-17
View on ClinicalTrials.gov ↗
from the ClinicalTrials.gov record
This study is to evaluate the effectiveness and safety of Ultimaster Tansei stent and/or Ultimaster Nagomi stent in the "real-world" daily practice.

Amendment record 6 amendments on the ClinicalTrials.gov record

This ClinicalTrials.gov record has been amended 6 times since 2020-06-21; most recent amendment 2026-06-24. DataLookout shows field-level changes from the day a trial enters its daily monitoring; earlier amendments are counted here from the ClinicalTrials.gov version history. See every version on ClinicalTrials.gov ↗

2020-12-16
Status change Not Yet RecruitingRecruitingv1
Trial Details
NCT Number NCT04443530
Lead Sponsor Duk-Woo Park, MD
Collaborators: CardioVascular Research Foundation, Korea
Conditions Coronary Artery Disease
Enrollment 2,000 participants
Start Date 2020-09-17
Primary Completion 2028-12-31 (estimated)
Study Completion 2032-12-31 (estimated)
Updated on ClinicalTrials.gov 2026-06-26